Literature DB >> 28839644

Improvement of parenteral nutrition-associated cholestasis in an adult using fish oil-based parenteral nutrition.

Lisa H Moyes1, Rizwana Hamid2, Juliet Clutton1, Karin A Oien3, Ruth F McKee1, Ewan H Forrest4.   

Abstract

Parenteral nutrition-associated cholestasis (PNAC) is a severe complication of parenteral nutrition. Standard feed preparations contain soybean and olive oil that are rich in ω-6 polyunsaturated fats, and which studies suggest can be hepatotoxic. Preparations containing fish oil, rich in ω-3 polyunsaturated fats, may be hepatoprotective and have been used in the critical care setting as immunotherapy. A case demonstrating dramatic improvement in liver function and overall clinical condition in an adult with PNAC and intestinal failure within 8 weeks of changing to a fish oil-based parenteral feed is reported. As far as is known, this is the first report of an adult patient whose parenteral nutrition-associated liver disease resolved after a parenteral nutrition lipid emulsion was changed to the fish oil-containing emulsion, SMOFlipid.

Entities:  

Year:  2012        PMID: 28839644      PMCID: PMC5517263          DOI: 10.1136/flgastro-2011-100056

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  10 in total

1.  Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alpha.

Authors:  Ewan H Forrest; K A Oien; S Dickson; D Galloway; P R Mills
Journal:  Liver       Date:  2002-08

2.  Chronic biochemical cholestasis in patients receiving home parenteral nutrition: prevalence and predisposing factors.

Authors:  D A J Lloyd; A A Zabron; S M Gabe
Journal:  Aliment Pharmacol Ther       Date:  2008-01-14       Impact factor: 8.171

3.  Use of N-acetyl cysteine for the treatment of parenteral nutrition-induced liver disease in children receiving home parenteral nutrition.

Authors:  Diana R Mager; Margaret Marcon; Paul Wales; Paul B Pencharz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-02       Impact factor: 2.839

4.  Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.

Authors:  Kathleen M Gura; Christopher P Duggan; Sharon B Collier; Russell W Jennings; Judah Folkman; Bruce R Bistrian; Mark Puder
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

Review 5.  Omega-3 lipids for intestinal failure associated liver disease.

Authors:  Ivan R Diamond; Paul B Pencharz; Paul W Wales
Journal:  Semin Pediatr Surg       Date:  2009-11       Impact factor: 2.754

6.  Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid.

Authors:  Hon M Cheung; Hugh S Lam; Yuk H Tam; Kim H Lee; Pak C Ng
Journal:  Clin Nutr       Date:  2009-03-04       Impact factor: 7.324

7.  Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.

Authors:  Kathleen M Gura; Sang Lee; Clarissa Valim; Jing Zhou; Sendia Kim; Biren P Modi; Danielle A Arsenault; Robbert A M Strijbosch; Suzanne Lopes; Christopher Duggan; Mark Puder
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

8.  Phytosterolemia in parenteral nutrition patients: implications for liver disease development.

Authors:  Josep M Llop; Núria Virgili; José M Moreno-Villares; Pilar García-Peris; Teresa Serrano; Maria Forga; Joan Solanich; Ana M Pita
Journal:  Nutrition       Date:  2008-07-24       Impact factor: 4.008

9.  Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).

Authors:  George Ekema; Diego Falchetti; Giovanni Boroni; Anna Rita Tanca; Cristian Altana; Laura Righetti; Michela Ridella; Marco Gambarotti; Luisa Berchich
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

Review 10.  Hepatobiliary, renal and bone complications of intestinal failure.

Authors:  Jeremy Mark Darby Nightingale
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-12       Impact factor: 3.043

  10 in total
  1 in total

Review 1.  Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.

Authors:  Fedja A Rochling
Journal:  Nutrients       Date:  2021-03-10       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.